ASH News Daily Seeks New Blood!

ASH is in search of the next team of authors for the 2021 ASH News Daily. If you are an ASH member (MD, PhD, or equivalent) who has a passion for writing as great as your love for hematology, you could be the right fit.

Ideal candidates are proficient, published writers who are curious about, and willing to cover, areas outside their comfort zone. You must be able to attend the annual meeting in December 2021, as well as one in-person board meeting two to three months prior. Interested candidates should have a flexible schedule at the annual meeting and be good with firm deadlines; enjoy science writing and be able to approach it creatively; and enjoy networking and doing author outreach.

If this sounds like you, please email Managing Editor Juana Llorens (jllorens@hematology.org) with a letter of interest, two writing samples, and your CV by June 3, 2021. For more information about ASH News Daily, visit www. hematology.org/Annual-Meeting/AND.aspx.

About

The content traditionally delivered in the daily meeting newspaper, ASH News Daily, will still be available to attendees each day in the virtual environment via e-blasts and pop up alerts on the virtual meeting platform.

The official website of ASH News Daily, www.ashnewsdaily.org, will cover the four days of the 2020 ASH Annual Meeting and feature informative articles on a wide range of Education and Scientific Program sessions and abstract presentations written by distinguished ASH members. Two print issues will be mailed to all ASH members and annual meeting registrants – one Preview issue sent in November, and one Wrap-Up issue sent in December.

Each issue of ASH News Daily will highlight the day’s sessions and events and will be linked from within the ASH Central section of the virtual meeting platform.

ASH News Daily 2020 Editorial Board

Editor

Ahmar Urooj Zaidi, MD (@drzsicklecell)

Ahmar Zaidi, MD, is a pediatric hematologist/oncologist at Children’s Hospital of Michigan in Detroit. Originally from Windsor, Ontario, he graduated from Medical University of the Americas and now specializes in sickle cell disease, hemoglobinopathies, and classical hematology. His other research interests include social media and wearable technology. Dr. Zaidi was an Author for the 2019 ASH News Daily board and is a member of the ASH Medical Educators Institute Class of 2019. His ultimate guilty pleasure is Cinnamon Toast Crunch cereal. Oh, and he also gave a TED Talk on sickle cell disease last year.

 

Authors

Alexander Glaros, MD (@AlexanderGlaros)

Dr. Alexander Glaros is a pediatric hematologist-oncologist at the Children’s Hospital of Michigan in Detroit. His clinical practice is predominantly in the care of pediatric sickle cell disease and classical hematology, with a research focus on mechanisms and management of pain in sickle cell disease. Originally from Royal Oak, Michigan, Dr. Glaros obtained his undergraduate degree from the University of Michigan and completed medical school at University of Toledo College of Medicine. He currently resides in Birmingham, Michigan, and has previously served as a junior author for the 2019 ASH News Daily. Dr. Glaros shared with us one of his unique skills — he can accurately perform the unique “hot dog dance” of every character on Mickey Mouse Clubhouse.

 

Danielle Hammond, MD (@DanielleHammo20)

Danielle Hammond, MD, is currently the Chief Leukemia Fellow at the University of Texas MD Anderson Cancer Center, with clinical interests in clonal hematopoiesis, acute leukemias, and inherited and acquired bone marrow failure syndromes. A Canadian, she received her hematology-oncology training at Queen’s University, Kingston, Ontario. For the past few years, she has been a contributing author to the Canadian Hematology Society newsletter, The Microenvironment.

Dr. Hammond grew up in the country amongst a family of veterinarians. “It is remarkable how similar the practice of oncology is in the veterinary world,” she notes. “When my family’s golden retriever was thought to have an aggressive B-cell lymphoma, frontline CHOP chemotherapy was offered. Anti-canine CD20 antibodies are still under development though, as the first-generation ones had disappointing antibody-dependent cellular cytotoxicity. Some would be surprised to learn that the National Cancer Institute has a Comparative Oncology Program and a Pre-medical Cancer Immunotherapy Network for Canine Trials.”

Dr. Hammond’s favorite discoveries in Texas are custom license plates and Topo Chico sparkling water. “My current ‘HEMQUEEN’ license plate was a wonderful gift. The other day I saw a Jeep in my building with a ‘N3PHRON’ plate, and I took the challenge personally — I just couldn’t ‘filter’ it out,” she quipped. “I am genuinely obsessed with lime Topo Chico; I have stashes at the hospital.”

Anand Padmanabhan, MD, PhD (@AnandPheresisMD)

Dr. Anand Padmanabhan is Senior Associate Consultant and Associate Professor in the Divisions of Hematopathology, Transfusion Medicine, and Experimental Pathology in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota. He received his medical degree from Thanjavur Medical College in India, his master’s degree and PhD from Brown University in Providence, Rhode Island, and underwent residency and fellowship training at the College of Physicians and Surgeons of Columbia University in New York, and the Institute for Transfusion Medicine in Pittsburgh, respectively. Dr. Padmanabhan is originally from Chennai, India, and currently resides in Rochester.

Dr. Padmanabhan directs a National Institutes of Health–funded laboratory focused on understanding the pathophysiology of heparin-induced thrombocytopenia, a dangerous thrombotic disorder, with an emphasis on translating research findings to improve diagnosis and treatment of this condition. Additionally, his interests include the evidence-based use of apheresis in human disease.

He is an American Society for Apheresis Representative in the ASH Committee on Practice and a member of the ASH Scientific Committee on Thrombosis and Vascular Biology. Dr. Padmanabhan is a dog lover and a cricket fanatic.

Elna Saah, MD (@sickledocmom)

Dr. Elna Saah is a pediatric hematologist/oncologist at The AFLAC Center for Cancer and Blood Disorders of Children’s HealthCare of Atlanta. She focuses primarily on nonmalignant hematology and sickle cell disease. Dr. Saah is an assistant professor of pediatrics at Emory University School of Medicine. Her clinical interests include transition from pediatric to adult care and chronic pain. Her scientific areas of interest are erythrocyte rheology and multi-omics applications in sickle cell disease.

Originally from Victoria, Cameroon, Dr. Saah attended The University of Nigeria Nsukka College of Medicine, Enugu Campus (home of the “great lions and lionesses!”) She considers herself a Michigander who has been currently transplanted to Atlanta, Georgia. Dr. Saah loves to read and travel, especially to destinations where there is water.

Angela Weyand, MD (@acweyand)

Dr. Angela Weyand is an assistant professor in the Department of Pediatrics, Division of Hematology and Oncology at the University of Michigan School of Medicine in Ann Arbor, Michigan. Her specialty is pediatric hematology with a focus on thrombosis and hemostasis, and her clinical and research interests include von Willebrand disease, bleeding and clotting disorders in young women and girls (Shemostasis), and using social media for medical education. “I love using tweetorials on benign hematology topics to teach on Twitter!” she shared.

Originally from a suburb of Kansas City, Kansas, Dr. Weyand obtained her undergraduate degree from Northwestern University, attended medical school at the University of Michigan (Go Blue!), and completed her pediatric residency at Seattle Children’s Hospital/University of Washington. She expanded her love of hematology in pediatric hematology/oncology fellowship at the University of Michigan in Ann Arbor, where she continues to live and practice.

Dr. Weyand has participated in several ASH initiatives. She presented a von Willebrand disease lecture for the new ASH Hematology Review Series and is involved in the development of the ASH Benign Hematology Curriculum.

While she is distinctively known as “Shematologist” on Twitter, her actual name has been the cause of a (in retrospect) funny incident in real life. She explained, “I once thought I was banned from visiting Australia as apparently there is a fugitive on the loose with my same name.”

 
Junior Author

Katherine Regling, DO (@kateregling)

Katherine Regling, DO, is a pediatric hematologist at Children’s Hospital of Michigan in Detroit. Her passion is caring for children with coagulation disorders, with a special interest in critical care hematologic issues.

 

 

 

Advertisement

Browse by Day

Share This